Drugs / Ginkgo Ketone Ester Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05855863 | Dec 2023 → Jun 2026 | dementia | Shanghai 10th People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo Ketone Ester Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05855863 ↗ |
| Known as | Styron | “Ginkgo biloba ketone ester tablets (Styron), taken orally, 3 times a day, 0.5g each time, and continuously administered for 6 months.” NCT05855863 ↗ |
| Route | Oral | “Ginkgo Ketone Ester Tablets taken orally, 3 times a day, 0.5g each time, combined with conventional hypoglycemic treatment for six months” NCT05855863 ↗ |